Loading clinical trials...
Loading clinical trials...
Alvesco for the Therapy of Persistent Asthma With or Without Allergic Component
Conditions
Interventions
Alvesco
Locations
79
Austria
Nycomed Pharma GmbH
Amstetten, Austria
Nycomed Pharma GmbH
Baden, Austria
Nycomed Pharma GmbH
Bludenz, Austria
Nycomed Pharma GmbH
Böhlerwerk, Austria
Nycomed Pharma GmbH
Braunau am Inn, Austria
Nycomed Pharma GmbH
Bregenz, Austria
Start Date
March 1, 2010
Primary Completion Date
May 1, 2011
Completion Date
August 1, 2011
Last Updated
December 5, 2016
NCT07486401
NCT02327897
NCT07219173
NCT04706988
NCT06406114
NCT04639791
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions